Paper32193227
B Cells Improve Overall Survival in HPV-Associated Squamous Cell Carcinomas and Are Activated by Radiation and PD-1 Blockade.
Kim SS and 9 others. Clin Cancer Res, 2020. Cited by 170 papers, by iCite.
Cite this record
ConductScience Library. B Cells Improve Overall Survival in HPV-Associated Squamous Cell Carcinomas and Are Activated by Radiation and PD-1 Blockade. Papers, record 32193227. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32193227
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- B Cells Improve Overall Survival in HPV-Associated Squamous Cell Carcinomas and Are Activated by Radiation and PD-1 Blockade.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| B-Lymphocytes | Major topic |
| Carcinoma, Squamous Cell | Major topic |
| Lymphocyte Activation | Major topic |
| Papillomavirus Infections | Major topic |
| Programmed Cell Death 1 Receptor | Major topic |
| Animals | |
| Biomarkers | |
| Cell Line, Tumor | |
| Disease Models, Animal | |
| Female | |
| Humans | |
| Mice | |
| Prognosis | |
| Radiotherapy | |
| Survival Analysis | |
| Treatment Outcome | |
| Xenograft Model Antitumor Assays |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| KL2 TR001444 | NCATS NIH HHS | United States | KL2TR001444 | PubMed and NIH | NIH RePORTER |
| P30 CA023100 | NCI NIH HHS | United States | P30CA023100 | PubMed and NIH | NIH RePORTER |
| L30 CA231829 | NCI NIH HHS | United States | L30CA231829 | PubMed and NIH | NIH RePORTER |
| U01 DE028227 | NIDCR NIH HHS | United States | U01DE028227 | PubMed and NIH | NIH RePORTER |
| R01 DE028563 | NIDCR NIH HHS | United States | R01DE028563 | PubMed and NIH | NIH RePORTER |
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19698134 | Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma. | BMC Cancer | 2009 | https://conductscience.org/library/papers/19698134 | PubMed |
| 2 | 28369882 | Worldwide burden of cancer attributable to HPV by site, country and HPV type. | Int J Cancer | 2017 | https://conductscience.org/library/papers/28369882 | PubMed |
| 3 | 24880458 | CD80 and PD-L2 define functionally distinct memory B cell subsets that are independent of antibody isotype. | Nat Immunol | 2014 | https://conductscience.org/library/papers/24880458 | PubMed |
| 4 | 29608179 | Integrating single-cell transcriptomic data across different conditions, technologies, and species. | Nat Biotechnol | 2018 | https://conductscience.org/library/papers/29608179 | PubMed |
| 5 | 27130719 | B cells promote tumor progression in a mouse model of HPV-mediated cervical cancer. | Int J Cancer | 2016 | https://conductscience.org/library/papers/27130719 | PubMed |
| 6 | 30104629 | Human germinal center transcriptional programs are de-synchronized in B cell lymphoma. | Nat Immunol | 2018 | https://conductscience.org/library/papers/30104629 | PubMed |
| 7 | 25527358 | Stereotactic Radiation Therapy Augments Antigen-Specific PD-1-Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen. | Cancer Immunol Res | 2015 | https://conductscience.org/library/papers/25527358 | PubMed |
| 8 | 29715484 | B cell MHC class II signaling: A story of life and death. | Hum Immunol | 2019 | https://conductscience.org/library/papers/29715484 | PubMed |
| 9 | 27462861 | Gene expression analysis of TIL rich HPV-driven head and neck tumors reveals a distinct B-cell signature when compared to HPV independent tumors. | Oncotarget | 2016 | https://conductscience.org/library/papers/27462861 | PubMed |
| 10 | 24004649 | Ontology based molecular signatures for immune cell types via gene expression analysis. | BMC Bioinformatics | 2013 | https://conductscience.org/library/papers/24004649 | PubMed |
| 11 | 22450810 | CD80 expression on B cells regulates murine T follicular helper development, germinal center B cell survival, and plasma cell generation. | J Immunol | 2012 | https://conductscience.org/library/papers/22450810 | PubMed |
| 12 | 30287641 | Cancer immunotherapy sweeps Nobel for medicine. | Science | 2018 | https://conductscience.org/library/papers/30287641 | PubMed |
| 13 | 27718784 | Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. | N Engl J Med | 2016 | https://conductscience.org/library/papers/27718784 | PubMed |
| 14 | 23296123 | Immunotherapy in new pre-clinical models of HPV-associated oral cancers. | Hum Vaccin Immunother | 2013 | https://conductscience.org/library/papers/23296123 | PubMed |
| 15 | 31519915 | B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma. | Nat Commun | 2019 | https://conductscience.org/library/papers/31519915 | PubMed |
| 16 | 28970196 | Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment. | Cancer Immunol Res | 2017 | https://conductscience.org/library/papers/28970196 | PubMed |
| 17 | 31942075 | B cells and tertiary lymphoid structures promote immunotherapy response. | Nature | 2020 | https://conductscience.org/library/papers/31942075 | PubMed |
| 18 | 31942077 | B cells are associated with survival and immunotherapy response in sarcoma. | Nature | 2020 | https://conductscience.org/library/papers/31942077 | PubMed |
| 19 | 24169351 | Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients. | Br J Cancer | 2013 | https://conductscience.org/library/papers/24169351 | PubMed |
| 20 | 20079667 | CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. | Immunity | 2010 | https://conductscience.org/library/papers/20079667 | PubMed |
Cited by123
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 170 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42726639 | B cell responses to CD40 stimulation ignite anti-tumor immunity by activating CD8+ T cell cytotoxicity. | Cell Rep | 2026 | https://conductscience.org/library/papers/42726639 | PubMed |
| 42606129 | Radiotherapy and immunotherapy in cancer treatment: mechanisms of clinical synergy. | J Clin Invest | 2026 | https://conductscience.org/library/papers/42606129 | PubMed |
| 42148142 | The immune microenvironment of HPV-associated cancers: from viral oncogenesis to immunotherapy response. | Front Immunol | 2026 | https://conductscience.org/library/papers/42148142 | PubMed |
| 41895712 | Spatial and phenotypic plasticity of B cells in remodeling the tumor microenvironment. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/41895712 | PubMed |
| 41800023 | The Role of B Cells in Tumorigenesis and Immunotherapy. | Immune Netw | 2026 | https://conductscience.org/library/papers/41800023 | PubMed |
| 41614894 | Gramine Suppresses Cervical Cancer by Targeting CDK2: Integrated Omics-Pharmacology and In Vitro Evidence. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/41614894 | PubMed |
| 41595735 | ANXA2P2 and PA2G4P4 Pseudogenes Are Associated with the Response to Ionizing Radiation and Could Be Used as Potential Biomarkers: In Silico Study. | Biomedicines | 2026 | https://conductscience.org/library/papers/41595735 | PubMed |
| 41593194 | Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade. | Nat Med | 2026 | https://conductscience.org/library/papers/41593194 | PubMed |
| 41462011 | CCL20 secreted by KRT15high tumor Cells promotes tertiary lymphoid structure formation and enhances anti-PD-1 therapy response in HPV+HNSCC. | Cell Death Dis | 2025 | https://conductscience.org/library/papers/41462011 | PubMed |
| 41429009 | A Machine Learning Model Based on Clinical Factors to Predict the Efficacy of First-Line Immunochemotherapy for Patients With Advanced Gastric Cancer: Retrospective Study. | JMIR Med Inform | 2025 | https://conductscience.org/library/papers/41429009 | PubMed |
| 41387521 | A machine learning-based framework for prognostic prediction and tumor microenvironment characterization of locally advanced cervical cancer with concurrent chemoradiotherapy. | NPJ Precis Oncol | 2025 | https://conductscience.org/library/papers/41387521 | PubMed |
| 41357192 | Unraveling the dual roles of tumor-infiltrating antibodies in solid tumors: friend or foe in the tumor microenvironment? | Front Immunol | 2025 | https://conductscience.org/library/papers/41357192 | PubMed |
| 41285707 | Targeting tumour-infiltrating B cells: mechanisms and advances in cancer therapy. | Cell Death Dis | 2025 | https://conductscience.org/library/papers/41285707 | PubMed |
| 41199110 | Advancements in single-cell sequencing for cervical cancer research. | Mol Cell Biochem | 2026 | https://conductscience.org/library/papers/41199110 | PubMed |
| 41088352 | Turning cold tumors into hot tumors to ignite immunotherapy. | Mol Cancer | 2025 | https://conductscience.org/library/papers/41088352 | PubMed |
| 40948758 | Targeting archetypes of viral-driven cancers with immunotherapy: a perspective on immunogenicity within the tumor microenvironment. | Front Immunol | 2025 | https://conductscience.org/library/papers/40948758 | PubMed |
| 40887652 | Overall survival of recurrent/metastatic head & neck squamous cell carcinoma patients progressing after ≥ 1 line of systemic therapy, treated with MVX-ONCO-1, a novel, first in class cell encapsulation-based immunotherapy: results of SAKK 11/16, a phase IIa trial. | Exp Hematol Oncol | 2025 | https://conductscience.org/library/papers/40887652 | PubMed |
| 40808954 | HPV infection and the immune microenvironment in cervical cancer. | Front Immunol | 2025 | https://conductscience.org/library/papers/40808954 | PubMed |
| 40781691 | Targeting immune microenvironment in cervical cancer: current research and advances. | J Transl Med | 2025 | https://conductscience.org/library/papers/40781691 | PubMed |
| 40664446 | Review: radiotherapy-mediated B cells within the TLS influence the tumor microenvironment. | J Immunother Cancer | 2025 | https://conductscience.org/library/papers/40664446 | PubMed |
Genes20
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32193227
GET https://conductscience.org/api/papers/v1/32193227/references?page=2